Apolipoprotein B100 secretion by cultured ARPE-19 cells is modulated by alteration of cholesterol levels

Journal of Neurochemistry

Volumn 114, Issue 6, 2010, Pages 1734-1744

  Wu, Tinghuai ^a   Fujihara, Masashi ^a   Tian, Jane ^a   Jovanovic, Miroslava ^b   Grayson, Celene ^b   Cano, Marisol ^a   Gehlbach, Peter ^a   Margaron, Philippe ^b   Handa, James T ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b QLT Inc   (United States)

Author keywords

age related macular degeneration; apolipoprotein B100; basal deposits; Bruch's membrane; drusen; retinal pigmented epithelium

Indexed keywords

APOLIPOPROTEIN B100; ATORVASTATIN; CERIVASTATIN; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LIPOPROTEIN; MEVINOLIN; OLEIC ACID; PRAVASTATIN; SIMVASTATIN; SULFUR 35; ANTIOXIDANT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIDINE DERIVATIVE; TRIACYLGLYCEROL;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CELL LEVEL; CULTURE MEDIUM; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; HYDROPHILICITY; IMMUNOPRECIPITATION; LIPOPHILICITY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; WESTERN BLOTTING; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; SECRETION (PROCESS);

ANTIOXIDANTS; APOLIPOPROTEIN B-100; CELL LINE; CELL SURVIVAL; CHOLESTEROL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; OLEIC ACID; PYRIDINES; TRIGLYCERIDES;

EID: 77956305733     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06884.x     Document Type: Article

References (64)

1. Bhakdi S., Dorweiler B., Kirchmann R., Torzewski J., Weise E., Tranum-Jensen J., Walev I. Wieland E. (1995) On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety. J. Exp. Med. 182, 1959 1971.
2. Bhakdi S., Torzewski M., Klouche M. Hemmes M. (1999) Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation. Arterioscler. Thromb. Vasc. Biol. 19, 2348 2354.
3. Boren J., Rustaeus S. Olofsson S. O. (1994) Studies on the assembly of apolipoprotein B-100- and B-48-containing very low density lipoproteins in McA-RH7777 cells. J. Biol. Chem. 269, 25879 25888.
4. Curcio C. A., Millican C. L., Bailey T. Kruth H. S. (2001) Accumulation of cholesterol with age in human Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 42, 265 274.
5. Curcio C. A., Presley J. B., Millican C. L. Medeiros N. E. (2005a) Basal deposits and drusen in eyes with age-related maculopathy: evidence for solid lipid particles. Exp. Eye Res. 80, 761 775.
6. Curcio C. A., Presley J. B., Malek G., Medeiros N. E., Avery D. V. Kruth H. S. (2005b) Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy. Exp. Eye Res. 81, 731 741.
7. Davidson M. H. Toth P. P. (2004) Comparative effects of lipid-lowering therapies. Prog. Cardiovasc. Dis. 47, 73 104.
8. Ershov A. V. Bazan N. G. (2000) Photoreceptor phagocytosis selectively activates PPARgamma expression in retinal pigment epithelial cells. J. Neurosci. Res. 60, 328 337.
9. Forte T. M. Nordhausen R. W. (1986) Electron microscopy of negatively stained lipoproteins. Methods Enzymol. 128, 442 457.
10. Fungwe T. V., Fox J. E., Cagen L. M., Wilcox H. G. Heimberg M. (1994) Stimulation of fatty acid biosynthesis by dietary cholesterol and of cholesterol synthesis by dietary fatty acid. J. Lipid Res. 35, 311 318.
11. Futterman S. Andrews J. S. (1964) The fatty acid composition of human retinal vitamin A ester and the lipids of human retinal tissue. Invest. Ophthalmol. 3, 441 444.
12. Goh E. H. Heimberg M. (1973) Stimulation of hepatic cholesterol biosynthesis by oleic acid. Biochem. Biophys. Res. Commun. 55, 382 388.
13. Green W. R., McDonnell P. J. Yeo J. H. (1985) Pathologic features of senile macular degeneration. Ophthalmology 92, 615 627.
14. Gulcan H. G., Alvarez R. A., Maude M. B. Anderson R. E. (1993) Lipids of human retina, retinal pigment epithelium, and Bruch's membrane/choroid: comparison of macular and peripheral regions. Invest. Ophthalmol. Vis. Sci. 34, 3187 3193.
15. Handa J. T., Reiser K. M., Matsunaga H. Hjelmeland L. M. (1998) The advanced glycation endproduct pentosidine induces the expression of PDGF-B in human retinal pigment epithelial cells. Exp. Eye Res. 66, 411 419.
16. Hofker M. H., van Vlijmen B. J. Havekes L. M. (1998) Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis. Atherosclerosis 137, 1 11.
17. Hrboticky N., Becker A., Kruse H. J. Weber P. C. (1997) Increased cellular triglyceride levels in human monocytic and rat smooth muscle cells after lovastatin. Biochim. Biophys. Acta 1349, 211 221.
18. Huff M. W. Burnett J. R. (1997) 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and hepatic apolipoprotein B secretion. Curr. Opin. Lipidol. 8, 138 145.
19. Ishibashi K., Tian J. Handa J. T. (2004) Similarity of mRNA phenotypes of morphologically normal macular and peripheral retinal pigment epithelial cells in older human eyes. Invest. Ophthalmol. Vis. Sci. 45, 3291 3301.
20. Ito M. K., Talbert R. L. Tsimikas S. (2006) Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction. Pharmacotherapy 26, 85S 97S. discussion 98S-101S; quiz 106S-108S.
21. Kalousova M., Zima T., Tesar V., Sulkova S. Fialova L. (2003) Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis patients. Kidney Int. Suppl. 84, S62 S64.
22. Kislinger T., Fu C., Huber B. et al. (1999) N(epsilon)-(carboxymethyl) lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J. Biol. Chem. 274, 31740 31749.
23. Klein R., Knudtson M. D. Klein B. E. (2007) Statin use and the five-year incidence and progression of age-related macular degeneration. Am. J. Ophthalmol. 144, 1 6.
24. van Kuijk F. J. Buck P. (1992) Fatty acid composition of the human macula and peripheral retina. Invest. Ophthalmol. Vis. Sci. 33, 3493 3496.
25. Lakkaraju A., Finnemann S. C. Rodriguez-Boulan E. (2007) The lipofuscin fluorophore A2E perturbs cholesterol metabolism in retinal pigment epithelial cells. Proc. Natl Acad. Sci. USA 104, 11026 11031.
26. Lee C. K., Allison D. B., Brand J., Weindruch R. Prolla T. A. (2002) Transcriptional profiles associated with aging and middle age-onset caloric restriction in mouse hearts. Proc. Natl Acad. Sci. USA 99, 14988 14993.
27. Leszczynska A., Burzynska B., Plochocka D., Kaminska J., Zimnicka M., Kania M., Kiliszek M., Wysocka-Kapcinska M., Danikiewicz W. Szkopinska A. (2009) Investigating the effects of statins on cellular lipid metabolism using a yeast expression system. PLoS ONE 4, e8499.
28. Li C. M., Presley J. B., Zhang X., Dashti N., Chung B. H., Medeiros N. E., Guidry C. Curcio C. A. (2005a) Retina expresses microsomal triglyceride transfer protein: implications for age-related maculopathy. J. Lipid Res. 46, 628 640.
29. Li C. M., Chung B. H., Presley J. B. et al. (2005b) Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization. Invest. Ophthalmol. Vis. Sci. 46, 2576 2586.
30. Li C. M., Clark M. E., Chimento M. F. Curcio C. A. (2006) Apolipoprotein localization in isolated drusen and retinal apolipoprotein gene expression. Invest. Ophthalmol. Vis. Sci. 47, 3119 3128.
31. Listenberger L. L. Schaffer J. E. (2002) Mechanisms of lipoapoptosis: implications for human heart disease. Trends Cardiovasc. Med. 12, 134 138.
32. Malek G., Li C. M., Guidry C., Medeiros N. E. Curcio C. A. (2003) Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Am. J. Pathol. 162, 413 425.
33. Martinez M., Ballabriga A. Gil-Gibernau J. J. (1988) Lipids of the developing human retina: I. Total fatty acids, plasmalogens, and fatty acid composition of ethanolamine and choline phosphoglycerides. J. Neurosci. Res. 20, 484 490.
34. McGwin Jr. G., Owsley C., Curcio C. A. Crain R. J. (2003) The association between statin use and age related maculopathy. Br. J. Ophthalmol. 87, 1121 1125.
35. McGwin Jr. G., Xie A. Owsley C. (2005) The use of cholesterol-lowering medications and age-related macular degeneration. Ophthalmology 112, 488 494.
36. McGwin Jr. G., Modjarrad K., Hall T. A., Xie A. Owsley C. (2006) 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors and the presence of age-related macular degeneration in the Cardiovascular Health Study. Arch. Ophthalmol. 124, 33 37.
37. McMillian M. K., Grant E. R., Zhong Z., Parker J. B., Li L., Zivin R. A., Burczynski M. E. Johnson M. D. (2001) Nile Red binding to HepG2 cells: an improved assay for in vitro studies of hepatosteatosis. In Vitr. Mol. Toxicol. 14, 177 190.
38. Miller Y. I., Chang M. K., Binder C. J., Shaw P. X. Witztum J. L. (2003) Oxidized low density lipoprotein and innate immune receptors. Curr. Opin. Lipidol. 14, 437 445.
39. Mohammadi A., Macri J., Newton R., Romain T., Dulay D. Adeli K. (1998) Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells. Arterioscler. Thromb. Vasc. Biol. 18, 783 793.
40. Pasha M. K., Muzeeb S., Basha S. J., Shashikumar D., Mullangi R. Srinivas N. R. (2006) Analysis of five HMG-CoA reductase inhibitors - atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies. Biomed. Chromatogr. 20, 282 293.
41. Ramasubbu K., Estep J., White D. L., Deswal A. Mann D. L. (2008) Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. J. Am. Coll. Cardiol. 51, 415 426.
42. Rise P., Ghezzi S., Priori I. Galli C. (2005) Differential modulation by simvastatin of the metabolic pathways in the n-9, n-6 and n-3 fatty acid series, in human monocytic and hepatocytic cell lines. Biochem. Pharmacol. 69, 1095 1100.
43. Ruberti J. W., Curcio C. A., Millican C. L., Menco B. P., Huang J. D. Johnson M. (2003) Quick-freeze/deep-etch visualization of age-related lipid accumulation in Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 44, 1753 1759.
44. Rudel L. L., Lee R. G. Cockman T. L. (2001) Acyl coenzyme A: cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis. Curr. Opin. Lipidol. 12, 121 127.
45. Sakamoto N., Tsuji K., Muul L. M. et al. (2007) Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humans. Blood 110, 501 508.
46. Severs N. J. Simons H. L. (1986) Caveolar bands and the effects of sterol-binding agents in vascular smooth muscle plasma membrane. Single and double labeling with filipin and tomatin in the aorta, pulmonary artery, and vena cava. Lab. Invest. 55, 295 307.
47. Smeeth L., Cook C., Chakravarthy U., Hubbard R. Fletcher A. E. (2005) A case control study of age related macular degeneration and use of statins. Br. J. Ophthalmol. 89, 1171 1175.
48. Soma M. R., Corsini A. Paoletti R. (1992) Cholesterol and mevalonic acid modulation in cell metabolism and multiplication. Toxicol. Lett. 64-65 Spec No, 1 15.
49. Sugii S., Reid P. C., Ohgami N., Shimada Y., Maue R. A., Ninomiya H., Ohno-Iwashita Y. Chang T. Y. (2003) Biotinylated theta-toxin derivative as a probe to examine intracellular cholesterol-rich domains in normal and Niemann-Pick type C1 cells. J. Lipid Res. 44, 1033 1041.
50. Tan J. S., Mitchell P., Rochtchina E. Wang J. J. (2007) Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study. Am. J. Ophthalmol. 143, 685 687.
51. Thelen K. M., Rentsch K. M., Gutteck U., Heverin M., Olin M., Andersson U., von Eckardstein A., Bjorkhem I. Lutjohann D. (2006) Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin. J. Pharmacol. Exp. Ther. 316, 1146 1152.
52. Tian J., Ishibashi K., Ishibashi K., Reiser K., Grebe R., Biswal S., Gehlbach P. Handa J. T. (2005) Advanced glycation endproduct-induced aging of the retinal pigment epithelium and choroid: a comprehensive transcriptional response. Proc. Natl Acad. Sci. USA 102, 11846 11851.
53. Tserentsoodol N., Gordiyenko N. V., Pascual I., Lee J. W., Fliesler S. J. Rodriguez I. R. (2006a) Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors. Mol. Vis. 12, 1319 1333.
54. Tserentsoodol N., Sztein J., Campos M., Gordiyenko N. V., Fariss R. N., Lee J. W., Fliesler S. J. Rodriguez I. R. (2006b) Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated process. Mol. Vis. 12, 1306 1318.
55. Twisk J., Gillian-Daniel D. L., Tebon A., Wang L., Barrett P. H. Attie A. D. (2000) The role of the LDL receptor in apolipoprotein B secretion. J. Clin. Invest. 105, 521 532.
56. Uesugi N., Sakata N., Nangaku M., Abe M., Horiuchi S., Hisano S. Iwasaki H. (2004) Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation. Am. J. Kidney Dis. 44, 224 238.
57. Vuletic S., Riekse R. G., Marcovina S. M., Peskind E. R., Hazzard W. R. Albers J. J. (2006) Statins of different brain penetrability differentially affect CSF PLTP activity. Dement. Geriatr. Cogn. Disord. 22, 392 398.
58. Wang L., Li C. M., Rudolf M., Curcio C. A., Peng D., Liu X. Zeng S. (2006) Gene expression of apolipoprotein and lipids synthesis and secretion in RPE-J cells. Yan Ke Xue Bao 22, 244 251.
59. Wang L., Li C. M., Rudolf M., Belyaeva O. V., Chung B. H., Messinger J. D., Kedishvili N. Y. Curcio C. A. (2009) Lipoprotein particles of intraocular origin in human Bruch membrane: an unusual lipid profile. Invest. Ophthalmol. Vis. Sci. 50, 870 877.
60. Wetterau J. R., Lin M. C. Jamil H. (1997) Microsomal triglyceride transfer protein. Biochim. Biophys. Acta 1345, 136 150.
61. Wilcox L. J., Barrett P. H. Huff M. W. (1999) Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin. J. Lipid Res. 40, 1078 1089.
62. Yamada Y., Tian J., Yang Y., Cutler R. G., Wu T., Telljohann R. S., Mattson M. P. Handa J. T. (2008) Oxidized low density lipoproteins induce a pathologic response by retinal pigmented epithelial cells. J. Neurochem. 105, 1187 1197.
63. Yokoyama M., Yagyu H., Hu Y., Seo T., Hirata K., Homma S. Goldberg I. J. (2004) Apolipoprotein B production reduces lipotoxic cardiomyopathy: studies in heart-specific lipoprotein lipase transgenic mouse. J. Biol. Chem. 279, 4204 4211.
64. Zhang Y. L., Hernandez-Ono A., Ko C., Yasunaga K., Huang L. S. Ginsberg H. N. (2004) Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles. J. Biol. Chem. 279, 19362 19374.